This Combined Synopsis/Solicitation opportunity from Department Of Health And Human Services was posted on September 18, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.
2D High-Density Multi-Electrode Array Electrophysiology Platform
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
Active Opportunities Like This One
AI Contract Overview
The U.S. Food and Drug Administration, through the Center for Drug Evaluation and Research, is soliciting quotations for a 2D High-Density Multi-Electrode Array (MEA) Electrophysiology Platform under RFQ_CBER-2026-135968. This unrestricted, firm-fixed-price acquisition includes the delivery of a complete platform with a dedicated workstation, a perpetual software license, five recording plates, and essential accessories. The scope of work encompasses on-site installation, system verification, calibration, and hands-on training for two government personnel. The system must be newly manufactured and capable of simultaneous recording from at least 2,000 electrodes per well to characterize drug-induced neural activity. Award will be made based on the Lowest Price Technically Acceptable (LPTA) method, with technical evaluations conducted on a pass/fail basis against mandatory minimum requirements. The contract includes a base requirement and three optional one-year periods for preventative maintenance and repair, with a total potential duration of five years and seventy-five calendar days. A two-year manufacturer warranty begins upon final government acceptance, which is contingent on a successful demonstration recording using control drugs and whole-network spatial activity visualization. Final acceptance will be communicated within five business days following the completion of all installation and verification activities. Quotations are due by September 23, 2026, and must include technical compliance documentation, pricing for all CLINs, and country of origin information in accordance with the Trade Agreements Act.
General Info
Timeline
Submission Closed
Organization & Contact Information
Full Description
The purpose of this amendment is to provide clarification regarding the Government’s final acceptance timeframe. No further questions will be addressed regarding this solicitation. The solicitation closing date and time will not be extended.
****************************************************************************************************************************************************
The U.S. Food and Drug Administration (FDA), Office of Acquisitions and Grants Services (OAGS), is issuing this combined synopsis/solicitation for the acquisition of a 2D High-Density Multi-Electrode Array (MEA) Electrophysiology Platform, including required hardware, software, accessories, initial consumables, installation, system verification, calibration, training, warranty coverage, and preventative maintenance option periods.
This solicitation is issued as a Request for Quotation (RFQ) for commercial products and services. This announcement constitutes the only solicitation; quotations are being requested, and a separate written solicitation will not be issued.
This requirement is being solicited on an unrestricted basis.
NAICS Code: 334516 – Analytical Laboratory Instrument Manufacturing
PSC: 6640 – Laboratory Equipment and Supplies
Set-Aside: None – Unrestricted
Basis for Award: Lowest Price Technically Acceptable (LPTA)
Award will be made to the responsible offeror whose quotation is determined to be technically acceptable and represents the lowest evaluated price. Technical acceptability will be evaluated on a pass/fail basis against the minimum requirements identified in the solicitation and attached Requirements Document. Quotations that fail to meet any mandatory minimum requirement may be determined technically unacceptable and will not be considered for award.
The solicitation includes a base requirement consisting of the equipment and associated supplies/services, a two-year warranty from final Government acceptance, and three one-year option periods for preventative maintenance and repair services.
The solicitation is subject to the Trade Agreements Act. Offerors shall provide the country of origin for all offered end products and complete all applicable representations and certifications.
Questions: All questions regarding this solicitation shall be submitted in writing no later than September 17, 2026, at 10:00 AM Eastern Time. Questions received after the deadline may not be answered. Responses to questions may be posted through an amendment to the solicitation.
Quotation Due Date: Quotations shall be submitted no later than September 23, 2026, at 10:00 AM Eastern Time.
Offerors shall submit a complete quotation that includes, at a minimum, technical documentation demonstrating compliance with the solicitation requirements, completed technical compliance information, pricing for the base requirement and all option periods, warranty information, delivery lead time, country of origin for all offered items, UEI, and confirmation of active SAM.gov registration.
All solicitation documents, attachments, amendments, and Government responses to questions will be posted to SAM.gov. Offerors are responsible for monitoring SAM.gov for amendments or other updates to this solicitation.
More opportunities from Department Of Health And Human Services → FDA Office Of Acq Grant Svcs
Same awarding agency
Find Active Opportunities Like This
Get AI-powered intelligence on the opportunities still open
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 750+ contractors already using CLEATUS
